Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

HIV Infection

Free Subscription 21.05.2018 18 AIDS 4 AIDS Res Hum Retroviruses 1 Am J Epidemiol 2 Antimicrob Agents Chemother 1 Blood 1 Cell 3 Clin Infect Dis 2 HIV Med 23 J Acquir Immune Defic Syndr 3 J Infect Dis 2 J Virol 1 MMWR Morb Mortal Wkly Rep 3 N Engl J Med 1 Pediatr Infect Dis J 14 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AIDS

1. CICHOWITZ C, Watt MH, Mmbaga BT
   Childbirth experiences of women living with HIV: a neglected event in the prevention of mother-to-child transmission care continuum.
   AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001860.
   PubMed     Text format    
   
   
2. GONG S, Tomusange K, Kulkarni V, Adeniji OS, et al
   Anti-HIV IgM protects against mucosal SHIV transmission.
   AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001857.
   PubMed     Text format     Abstract available
   
   
3. WINCKELMANN A, Morcilla V, Shao W, Schleimann MH, et al
   Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1 infected individuals.
   AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001861.
   PubMed     Text format     Abstract available
   
   
4. TSUKAMOTO T
   Transcriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34+ cells in HIV-1 infection.
   AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001882.
   PubMed     Text format     Abstract available
   
   
5. BARNES A, Betts AC, Borton EK, Sanders JM, et al
   Cervical cancer screening among HIV infected women in an urban, U.S. safety-net healthcare system.
   AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001881.
   PubMed     Text format     Abstract available
   
   
6. YANG J, Sharma A, Shi Q, Anastos K, et al
   Improved fracture prediction using different FRAX adjustments in HIV-infected women.
   AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001864.
   PubMed     Text format     Abstract available
   
   
7. MOYO S, Gaseitsiwe S, Powis KM, Pretorius Holme M, et al
   Undisclosed antiretroviral drug use in Botswana: implication for national estimates.
   AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001862.
   PubMed     Text format     Abstract available
   
   
8. ALUISIO AR, Palaniappan A, Farquhar C, Mello MJ, et al
   Integrated HIV-injury programming: An underutilized intersection to engage young adults in HIV care in low- and middle-income countries.
   AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001876.
   PubMed     Text format     Abstract available
   
   
9. DUFFAU P, Ozanne A, Bonnet F, Lazaro E, et al
   Multimorbidity, age-related comorbidities and mortality: association of activation, senescence and inflammation markers in HIV adults.
   AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001875.
   PubMed     Text format     Abstract available
   
   
10. HOORNENBORG E, Coyer L, van Laarhoven A, Achterbergh R, et al
    Change in sexual risk behaviour after six months of pre-exposure prophylaxis use: results from the Amsterdam PrEP demonstration project.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001874.
    PubMed     Text format     Abstract available
    
    
11. DILLON SM, Guo K, Austin GL, Gianella S, et al
    A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001863.
    PubMed     Text format     Abstract available
    
    
12. MOLSBERRY SA, Cheng Y, Kingsley L, Jacobson L, et al
    Neuropsychological phenotypes among men with and without HIV disease in the multicenter AIDS cohort study.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001865.
    PubMed     Text format     Abstract available
    
    
13. KILBURN K, Ranganathan M, Stoner MCD, Hughes JP, et al
    Transactional sex and incident HIV infection in a cohort of young women from rural South Africa enrolled in HPTN 068.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001866.
    PubMed     Text format     Abstract available
    
    
14. HEFFRON R, Mugo N, Hong T, Celum C, et al
    Pregnancy outcomes and infant growth among babies with in utero exposure to tenofovir-based pre-exposure prophylaxis for HIV prevention.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001867.
    PubMed     Text format     Abstract available
    
    
15. MONTGOMERY ET, Stadler J, Naidoo S, Katz A, et al
    Reasons for non-adherence to the dapivirine vaginal ring: results of the MTN-032/ AHA study.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001868.
    PubMed     Text format     Abstract available
    
    
16. KONG D, Wang Y, Ji P, Li W, et al
    A defucosylated bispecific multivalent molecule exhibits broad HIV-1 neutralizing activity and enhanced ADCC against reactivated HIV-1 latently infected cells.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001869.
    PubMed     Text format     Abstract available
    
    
17. HARRIS TG, Rabkin M, El-Sadr WM
    Achieving the 4th 90 - Healthy Aging for People Living with HIV.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001870.
    PubMed     Text format    
    
    
18. WOODSON E, Goldberg A, Michelo C, Basu D, et al
    HIV transmission in Discordant Couples in Africa in the context of ART availability.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001871.
    PubMed     Text format     Abstract available
    
    

    
    AIDS Res Hum Retroviruses

19. HIRANSUTHIKUL A, Wongkanya R, Sirivichayakul S, Trachunthong D, et al
    Discordance in drug-resistance mutations between blood plasma and semen or rectal secretion among newly diagnosed HIV-1-infected Thai MSM.
    AIDS Res Hum Retroviruses. 2018 May 14. doi: 10.1089/AID.2018.0029.
    PubMed     Text format     Abstract available
    
    
20. DUKHOVLINOVA E, Masharsky A, Vasileva A, Porrello A, et al
    Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use.
    AIDS Res Hum Retroviruses. 2018 May 14. doi: 10.1089/AID.2017.0313.
    PubMed     Text format     Abstract available
    
    
21. STEKLER J, Tapia K, Maenza J, Stevens CE, et al
    No time to delay! Fiebig stages and referral in acute HIV infection: Seattle Primary Infection Program Experience.
    AIDS Res Hum Retroviruses. 2018 May 14. doi: 10.1089/AID.2017.0276.
    PubMed     Text format     Abstract available
    
    
22. MICHAL JL, Rab S, Patel M, Kyle A, et al
    Incidence of acute kidney injury in patients co-infected with HIV and hepatitis C virus receiving tenofovir disoproxil fumarate and ledipasvir/sofosbuvir in a real-world, urban, Ryan White clinic.
    AIDS Res Hum Retroviruses. 2018 May 16. doi: 10.1089/AID.2017.0271.
    PubMed     Text format     Abstract available
    
    

    
    Am J Epidemiol

23. BRENNAN AT, Bor J, Davies MA, Wandeler G, et al
    Drug Side Effects and Retention on HIV Treatment: a Regression Discontinuity Study of Tenofovir Implementation in South Africa and Zambia.
    Am J Epidemiol. 2018 May 15. pii: 4996076. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Antimicrob Agents Chemother

24. BANDA CG, Dzinjalamala F, Mukaka M, Mallewa J, et al
    Pharmacokinetics and safety profile of artesunate-amodiaquine co-administered with antiretroviral therapy in malaria uninfected HIV-positive Malawian adults.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00412.
    PubMed     Text format     Abstract available
    
    
25. FOCA E, Calcagno A, Bonito A, Cusato J, et al
    Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00309.
    PubMed     Text format     Abstract available
    
    

    
    Blood

26. GOPAL S, Gross TG
    How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa.
    Blood. 2018 May 16. pii: blood-2018-04-844472. doi: 10.1182/blood-2018-04-844472
    PubMed     Text format     Abstract available
    
    

    
    Cell

27. HANSEN MMK, Wen WY, Ingerman E, Razooky BS, et al
    A Post-Transcriptional Feedback Mechanism for Noise Suppression and Fate Stabilization.
    Cell. 2018 May 4. pii: S0092-8674(18)30458-6. doi: 10.1016/j.cell.2018.
    PubMed     Text format     Abstract available
    
    

    
    Clin Infect Dis

28. LAMBERT-NICLOT S, Grude M, Meynard JL, Marcelin AG, et al
    Ultrasensitive HIV-1 Viral Load as a Marker of Treatment Choice for Simplification Strategies.
    Clin Infect Dis. 2018 May 15. pii: 4996083. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
29. ELLIOT ER, Wang X, Singh S, Simmons B, et al
    Increased dolutegravir peak concentrations in people living with HIV aged 60 and over and analysis of sleep quality and cognition.
    Clin Infect Dis. 2018 May 16. pii: 4996575. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
30. ZHAO Y, Wu Z, McGoogan JM, Sha Y, et al
    Nationwide cohort study of antiretroviral therapy timing: treatment dropout and virological failure in China, 2011-2015.
    Clin Infect Dis. 2018 May 16. pii: 4996605. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    HIV Med

31. TRUNFIO M, Vai D, Montrucchio C, Alcantarini C, et al
    Diagnostic accuracy of new and old cognitive screening tools for HIV-associated neurocognitive disorders.
    HIV Med. 2018 May 15. doi: 10.1111/hiv.12622.
    PubMed     Text format     Abstract available
    
    
32. GUO F, Cheng X, Hsieh E, Du X, et al
    Prospective plasma efavirenz concentration assessment in Chinese HIV-infected adults enrolled in a large multicentre study.
    HIV Med. 2018 May 15. doi: 10.1111/hiv.12607.
    PubMed     Text format     Abstract available
    
    

    
    J Acquir Immune Defic Syndr

33. SHIAU S, Strehlau R, Shen J, Violari A, et al
    Biomarkers of aging in HIV-infected children on suppressive antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2018 Apr 27. doi: 10.1097/QAI.0000000000001714.
    PubMed     Text format     Abstract available
    
    
34. GOLOVATY I, Sharma M, Van Heerden A, van Rooyen H, et al
    Cost of integrating non-communicable disease screening into home-based HIV testing and counseling in South Africa.
    J Acquir Immune Defic Syndr. 2018 May 10. doi: 10.1097/QAI.0000000000001713.
    PubMed     Text format     Abstract available
    
    
35. THIRUMURTHY H, Masters SH, Agot K
    Willingness to Pay for HIV Self-Tests Among Women in Kenya: Implications for Subsidy and Pricing Policies.
    J Acquir Immune Defic Syndr. 2018;78:e8-e11.
    PubMed     Text format    
    
    
36. RANZANI A, Oreni L, Agro M, van den Bogaart L, et al
    Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
    J Acquir Immune Defic Syndr. 2018;78:193-201.
    PubMed     Text format     Abstract available
    
    
37. JUSTMAN JE, Nair GL, Hendrix CW, Piper JM, et al
    Pharmacokinetics and Pharmacodynamics of Tenofovir Reduced-Glycerin 1% Gel in the Rectal and Vaginal Compartments in Women: A Cross-Compartmental Study With Directly Observed Dosing.
    J Acquir Immune Defic Syndr. 2018;78:175-182.
    PubMed     Text format     Abstract available
    
    
38. JOTWANI V, Scherzer R, Glidden DV, Mehrotra M, et al
    Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals.
    J Acquir Immune Defic Syndr. 2018;78:169-174.
    PubMed     Text format     Abstract available
    
    
39. MAUGHAN-BROWN B, George G, Beckett S, Evans M, et al
    HIV Risk Among Adolescent Girls and Young Women in Age-Disparate Partnerships: Evidence From KwaZulu-Natal, South Africa.
    J Acquir Immune Defic Syndr. 2018;78:155-162.
    PubMed     Text format     Abstract available
    
    
40. 
    Neutrophil Activation and Enhanced Release of Granule Products in HIV-TB Immune Reconstitution Inflammatory Syndrome: Erratum.
    J Acquir Immune Defic Syndr. 2018;78:e13.
    PubMed     Text format    
    
    
41. RADTKE KK, Bacchetti P, Anastos K, Merenstein D, et al
    Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort Study.
    J Acquir Immune Defic Syndr. 2018;78:202-208.
    PubMed     Text format     Abstract available
    
    
42. BURGER EA, Dyer MA, Sy S, Palefsky JM, et al
    Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men.
    J Acquir Immune Defic Syndr. 2018 May 9. doi: 10.1097/QAI.0000000000001727.
    PubMed     Text format     Abstract available
    
    
43. NOVITSKY V, Gaolathe T, Mmalane M, Moyo S, et al
    Lack of Virological Suppression among Young HIV-Positive Adults in Botswana.
    J Acquir Immune Defic Syndr. 2018 Apr 27. doi: 10.1097/QAI.0000000000001715.
    PubMed     Text format     Abstract available
    
    
44. DYER TV, Khan MR, Regan R, Harawa NT, et al
    Differential Patterns of Risk and Vulnerability Suggest the Need for Novel Prevention Strategies for Black Bisexual Men in the HPTN 061 Study.
    J Acquir Immune Defic Syndr. 2018 May 10. doi: 10.1097/QAI.0000000000001716.
    PubMed     Text format     Abstract available
    
    
45. MERLIN JS, Long D, Becker WC, Cachay ER, et al
    The Association of Chronic Pain and Long-Term Opioid Therapy with HIV Treatment Outcomes.
    J Acquir Immune Defic Syndr. 2018 May 4. doi: 10.1097/QAI.0000000000001741.
    PubMed     Text format     Abstract available
    
    
46. LIGHTFOOT MA, Campbell CK, Moss N, Treves-Kagan S, et al
    Using a Social Network Strategy to Distribute HIV Self-Test Kits to African American and Latino MSM.
    J Acquir Immune Defic Syndr. 2018 May 4. doi: 10.1097/QAI.0000000000001726.
    PubMed     Text format     Abstract available
    
    
47. GUITEAU MOISE C, Rivera VR, Hennessey KA, Bellot C, et al
    A Successful Model of Expedited Antiretroviral Therapy for Clinically Stable Patients Living with HIV in Haiti.
    J Acquir Immune Defic Syndr. 2018 Apr 30. doi: 10.1097/QAI.0000000000001725.
    PubMed     Text format     Abstract available
    
    
48. CAHN P, Sax PE, Squires K, Molina JM, et al
    Raltegravir 1200 mg once daily vs 400 mg twice daily, with emtricitabine and tenofovir disoproxil fumarate, for previously untreated HIV-1 infection: Week 96 results from ONCEMRK, a randomized, double-blind, non-inferiority trial.
    J Acquir Immune Defic Syndr. 2018 May 3. doi: 10.1097/QAI.0000000000001723.
    PubMed     Text format     Abstract available
    
    
49. ACHHRA AC, Sabin C, Ryom L, Hatleberg C, et al
    Body Mass Index and The Risk of Serious Non-Aids Events and All Cause Mortality in Treated Hiv-Positive Individuals: D: A: D Cohort Analysis.
    J Acquir Immune Defic Syndr. 2018 May 3. doi: 10.1097/QAI.0000000000001722.
    PubMed     Text format     Abstract available
    
    
50. WAKE RM, Jarvis JN, Harrison TS, Govender NP, et al
    Point of Care Cryptococcal Antigen Screening: Pipetting Finger-Prick Blood Improves Performance of Immuno-Mycologics Lateral Flow Assay.
    J Acquir Immune Defic Syndr. 2018 Apr 30. doi: 10.1097/QAI.0000000000001721.
    PubMed     Text format     Abstract available
    
    
51. BALAN IC, Frasca T, Dolezal C, Carballo-Dieguez A, et al
    HIV Risk Reduction by Avoiding Sex with Partners Unwilling to Undergo HIV Testing is Not Coercion.
    J Acquir Immune Defic Syndr. 2018 May 4. doi: 10.1097/QAI.0000000000001740.
    PubMed     Text format    
    
    
52. VON BRAUN A, Sekaggya-Wiltshire C, Bachmann N, Ssemwanga D, et al
    HIV-1 drug resistance among Ugandan adults attending an urban out-patient clinic.
    J Acquir Immune Defic Syndr. 2018 Apr 27. doi: 10.1097/QAI.0000000000001717.
    PubMed     Text format     Abstract available
    
    
53. SHERMAN KE, Rouster SD, Kong LX, Shata TM, et al
    Zika Virus Exposure in an HIV-Infected Cohort in Ghana.
    J Acquir Immune Defic Syndr. 2018 Apr 27. doi: 10.1097/QAI.0000000000001718.
    PubMed     Text format     Abstract available
    
    
54. YANIK EL, Hernandez-Ramirez RU, Qin L, Lin H, et al
    Cutaneous Melanoma Risk among People with HIV in the United States and Canada.
    J Acquir Immune Defic Syndr. 2018 Apr 27. doi: 10.1097/QAI.0000000000001719.
    PubMed     Text format     Abstract available
    
    
55. LOPEZ-VARELA E, Fuente-Soro L, Augusto OJ, Sacoor C, et al
    The Continuum of HIV Care in Rural Mozambique: The Implications of HIV Testing Modality on Linkage and Retention.
    J Acquir Immune Defic Syndr. 2018 Apr 27. doi: 10.1097/QAI.0000000000001720.
    PubMed     Text format     Abstract available
    
    

    
    J Infect Dis

56. TWISK DE, van der Sande MAB, van Eeden A, Heideman DAM, et al
    Detection of Incident Anal High-Risk Hpv-Dna in Msm: Incidence or Reactivation?
    J Infect Dis. 2018 May 16. pii: 4996623. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
57. KOAY WLA, Lindsey JC, Uprety P, Bwakura-Dangarembizi M, et al
    Intestinal Integrity Biomarkers in Early Antiretroviral-Treated Perinatally HIV-1-Infected Infants.
    J Infect Dis. 2018 May 12. pii: 4995578. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
58. REICHLER MR, Khan A, Sterling TR, Zhao H, et al
    Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis.
    J Infect Dis. 2018 May 15. pii: 4996045. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Virol

59. CAREY BD, Ammosova T, Pinkham C, Lin X, et al
    Protein Phosphatase 1alpha Interacts with Venezuelan Equine Encephalitis Virus Capsid Protein and Regulates Viral Replication through Modulation of Capsid Phosphorylation.
    J Virol. 2018 May 16. pii: JVI.02068-17. doi: 10.1128/JVI.02068.
    PubMed     Text format     Abstract available
    
    
60. KUMAR S, Morrison JH, Dingli D, Poeschla E, et al
    HIV-1 activation of innate immunity depends strongly on the intracellular level of TREX1 and sensing of incomplete reverse transcription products.
    J Virol. 2018 May 16. pii: JVI.00001-18. doi: 10.1128/JVI.00001.
    PubMed     Text format     Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

61. BURRAGE A, Patel M, Mirkovic K, Dziuban E, et al
    Trends in Antiretroviral Therapy Eligibility and Coverage Among Children Aged <15 Years with HIV Infection - 20 PEPFAR-Supported Sub-Saharan African Countries, 2012-2016.
    MMWR Morb Mortal Wkly Rep. 2018;67:552-555.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

62. GOMEZ CA, Banaei N
    Trypanosoma cruzi Reactivation in the Brain.
    N Engl J Med. 2018;378:1824.
    PubMed     Text format    
    
    
63. ZUGER A
    Moving On.
    N Engl J Med. 2018;378:1763-1765.
    PubMed     Text format    
    
    
64. JUSTMAN JE, Mugurungi O, El-Sadr WM
    HIV Population Surveys - Bringing Precision to the Global Response.
    N Engl J Med. 2018;378:1859-1861.
    PubMed     Text format    
    
    

    
    Pediatr Infect Dis J

65. HUIBERS MHW, Moons P, Maseko N, Gushu MB, et al
    Multiplex Real-Time PCR Detection of Intestinal Protozoa in HIV-Infected Children in Malawi, Enterocytozoon Bieneusi is Common and Associated with Gastrointestinal Complaints and May Delay BMI (Nutritional Status) Recovery.
    Pediatr Infect Dis J. 2018 May 14. doi: 10.1097/INF.0000000000001924.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

66. JOSEPH DAVEY D, Farley E, Towriss C, Gomba Y, et al
    Risk perception and sex behaviour in pregnancy and breastfeeding in high HIV prevalence settings: Programmatic implications for PrEP delivery.
    PLoS One. 2018;13:e0197143.
    PubMed     Text format     Abstract available
    
    
67. LILIAN RR, Railton J, Schaftenaar E, Mabitsi M, et al
    Strengthening primary eye care in South Africa: An assessment of services and prospective evaluation of a health systems support package.
    PLoS One. 2018;13:e0197432.
    PubMed     Text format     Abstract available
    
    
68. DUTTA D, Johnson S, Dalal A, Deymier MJ, et al
    High throughput generation and characterization of replication-competent clade C transmitter-founder simian human immunodeficiency viruses.
    PLoS One. 2018;13:e0196942.
    PubMed     Text format     Abstract available
    
    
69. CHANG RC, Hail-Jares K, Zheng H, He N, et al
    Mitigating circumstances: A model-based analysis of associations between risk environment and infrequent condom use among Chinese street-based sex workers.
    PLoS One. 2018;13:e0195982.
    PubMed     Text format     Abstract available
    
    
70. MARTIN-CANAVATE R, Sonego M, Sagrado MJ, Escobar G, et al
    Dietary patterns and nutritional status of HIV-infected children and adolescents in El Salvador: A cross-sectional study.
    PLoS One. 2018;13:e0196380.
    PubMed     Text format     Abstract available
    
    
71. MCCREESH N, Andrianakis I, Nsubuga RN, Strong M, et al
    Choice of time horizon critical in estimating costs and effects of changes to HIV programmes.
    PLoS One. 2018;13:e0196480.
    PubMed     Text format     Abstract available
    
    
72. YAYLALI E, Farnham PG, Cohen S, Purcell DW, et al
    Optimal allocation of HIV prevention funds for state health departments.
    PLoS One. 2018;13:e0197421.
    PubMed     Text format     Abstract available
    
    
73. PATHMANATHAN I, Pasipamire M, Pals S, Dokubo EK, et al
    High uptake of antiretroviral therapy among HIV-positive TB patients receiving co-located services in Swaziland.
    PLoS One. 2018;13:e0196831.
    PubMed     Text format     Abstract available
    
    
74. FELLOWS IE, Morris M, Birnbaum JK, Dombrowski JC, et al
    Correction: A New Method for Estimating the Number of Undiagnosed HIV Infected Based on HIV Testing History, with an Application to Men Who Have Sex with Men in Seattle/King County, WA.
    PLoS One. 2018;13:e0197707.
    PubMed     Text format     Abstract available
    
    
75. SUTTON MY, Zhou W, Frazier EL
    Unplanned pregnancies and contraceptive use among HIV- positive women in care.
    PLoS One. 2018;13:e0197216.
    PubMed     Text format     Abstract available
    
    
76. BORTHWICK NJ, Lane T, Moyo N, Crook A, et al
    Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1.
    PLoS One. 2018;13:e0197299.
    PubMed     Text format     Abstract available
    
    
77. YOURKAVITCH J, Hassmiller Lich K, Flax VL, Okello ES, et al
    Interactions among poverty, gender, and health systems affect women's participation in services to prevent HIV transmission from mother to child: A causal loop analysis.
    PLoS One. 2018;13:e0197239.
    PubMed     Text format     Abstract available
    
    
78. EJIGU BA, Wencheko E, Berhane K
    Spatial pattern and determinants of anaemia in Ethiopia.
    PLoS One. 2018;13:e0197171.
    PubMed     Text format     Abstract available
    
    
79. GUTHRIE KM, Rosen RK, Vargas SE, Getz ML, et al
    User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences.
    PLoS One. 2018;13:e0197269.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: